Mindpeak

Mindpeak is an AI pathology company founded in 2018 and headquartered in Hamburg, Germany, with an additional office in Cambridge, Massachusetts. It was built to help pathologists and drug developers extract measurable biomarker data from tissue samples that is otherwise inconsistent when scored by eye, a bottleneck in cancer diagnostics and precision-medicine research.

Its software suite turns digitised tissue slides into quantified data, covering biomarker discovery, therapy-response prediction, multi-modal image analysis and specimen quality checks, with CE-IVD marked modules for breast cancer, PD-L1 and HER2 scoring. Customers include diagnostic laboratories, hospitals and pharmaceutical companies such as Unilabs and Intermountain Health, and the technology is also distributed globally through a reseller agreement with Leica Biosystems.

1. Phenoscout AI: Discovers quantifiable biomarkers from digitised tissue images.

2. peakPredict: Forecasts therapy response from pathology data.

3. peakDeploy: Runs multi-modal image analysis across scanner types.

4. peakDissect: Checks and optimises tissue specimen quality before analysis.

5. Diagnostic Suites: CE-IVD marked modules for breast cancer, PD-L1 and HER2 scoring.

6. Global Distribution: Reaches laboratories worldwide via a Leica Biosystems reseller deal.